article thumbnail

The debate on DTC marketing is going to heat up again

World of DTC Marketing

DTC ads do NOT lead to unnecessary Rxs. The FDA needs to study what people do when they see a DTC ad. Today, people don’t see a DTC TV ad and run to their doctor to ask for an Rx. 4our: DTC marketing should be illegal because it leads to unnecessary Rx’s. Still, the gatekeeper continues to be their doctor.

Marketing 285
article thumbnail

Do patients care about accelerated approval drugs?

World of DTC Marketing

Accelerated Approval was developed in 1992 in response to the HIV/AIDS crisis and has led to expedited drug and biologic approvals in several disease areas across the FDA. Of course, they should, but in the end, it’s going to come down to trust in their doctor and the FDA. Do patients care?

Patients 200
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

A scientific approach to irrational consumer choices

World of DTC Marketing

GOOD MORNING: The FDA is taking a scientific approach to evaluating direct-to-consumer (DTC) drug advertising, focusing on measuring consumer perceptions of the information presented in ads. ” So, are we supposed to believe that better images in DTC ads lead to patients asking for an Rx? ” Uh…no.

article thumbnail

FDA-Approved At-Home Spirometer: Interview with Charvi Shetty, Co-Founder and CEO at Aluna

Medgadget

Left uncontrolled and improperly managed, these conditions can progress to attacks that lead to avoidable ED visits and hospitalization. Doctors can now intervene earlier and more effectively in managing their patients’ care. Unfortunately, COVID can cause symptoms for patients with chronic lung conditions to worsen severely.

Doctors 93
article thumbnail

Jazz Pharma uses flying pig for huge grey area DTC

World of DTC Marketing

This has abuse potential written all over it and could lead to more dangerous health problems. I can see patients asking their doctor for this medication to combat fatigue that we all experience at some time. I can see patients asking their doctor for this medication to combat fatigue that we all experience at some time.

Pharma 181
article thumbnail

FDA makes moves to advance ALS research ahead of upcoming Amylyx AdCom

Pharmaceutical Technology

In the lead-up to a critical meeting that will influence the approval of a new drug for amyotrophic lateral sclerosis (ALS), the US Food and Drug Administration (FDA) has detailed its plans to advance rare neurodegenerative disease research. The FDA’s action plan. The first AdCom was critical of the study’s robustness.

FDA 98
article thumbnail

Biogen’s Alzheimer’s drug: What’s the price tag on hope?

World of DTC Marketing

SUMMARY: The FDA is coming under intense pressure to approve Biogen’s Alzheimer’s drug, but Aaron S. Too many doctors, the data was still questionable. Knopman, a Mayo Clinic neurologist who treats Alzheimer’s patients and is a member of the FDA advisory committee.